The emerging class of GLP-1 agonist medication and GIP dual medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, offer significant advances in diabetes treatment . https://peptide-certificate-of-a191619.119blog.com/62078944/semaglutide-a-detailed-look